Cargando…

Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System

2-arylbenzofurans represent a small group of bioactive compounds found in the plant family Moraceae. As it has not been investigated whether these substances are stable during passage through the gastrointestinal tract, their biological effects may be altered by the metabolism of intestinal microbio...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesely, Ondrej, Marsik, Petr, Jarosova, Veronika, Doskocil, Ivo, Smejkal, Karel, Kloucek, Pavel, Havlik, Jaroslav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625357/
https://www.ncbi.nlm.nih.gov/pubmed/34829035
http://dx.doi.org/10.3390/foods10112754
_version_ 1784606401647083520
author Vesely, Ondrej
Marsik, Petr
Jarosova, Veronika
Doskocil, Ivo
Smejkal, Karel
Kloucek, Pavel
Havlik, Jaroslav
author_facet Vesely, Ondrej
Marsik, Petr
Jarosova, Veronika
Doskocil, Ivo
Smejkal, Karel
Kloucek, Pavel
Havlik, Jaroslav
author_sort Vesely, Ondrej
collection PubMed
description 2-arylbenzofurans represent a small group of bioactive compounds found in the plant family Moraceae. As it has not been investigated whether these substances are stable during passage through the gastrointestinal tract, their biological effects may be altered by the metabolism of intestinal microbiota or cells. The aim of the present study was to investigate and compare mulberrofuran Y (1), moracin C (2), and mulberrofuran G (3) in an in vitro model of human intestinal bacterial fermentation and in an epithelial model using the Caco-2 cell line. The analysis of compounds by LC-MS-Q-TOF showed sufficient stability in the fermentation model, with no bacterial metabolites detected. However, great differences in the quantity of permeation were observed in the permeability assay. Moreover, mulberrofuran Y (1) and moracin C (2) were observed to be transformed into polar metabolites by conjugation. Among the test compounds, mulberrofuran Y (1) was mostly stable and accumulated in endothelial cells (85.3%) compared with mulberrofuran G (3) and moracin C (2) (14% and 8.2%, respectively). Thus, only a small amount of mulberrofuran Y (1) was conjugated. Moracin C (2) and mulberrofuran G (3) were metabolized almost completely, with only traces of the unchanged molecule being found on the apical and cellular sides of the system. Only conjugates of mulberrofuran Y (1) and moracin C (2) were able to reach the basolateral side. Our results provide the basic description of bioavailability of these three compounds, which is a necessary characteristic for final evaluation of bio-efficacy.
format Online
Article
Text
id pubmed-8625357
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86253572021-11-27 Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System Vesely, Ondrej Marsik, Petr Jarosova, Veronika Doskocil, Ivo Smejkal, Karel Kloucek, Pavel Havlik, Jaroslav Foods Article 2-arylbenzofurans represent a small group of bioactive compounds found in the plant family Moraceae. As it has not been investigated whether these substances are stable during passage through the gastrointestinal tract, their biological effects may be altered by the metabolism of intestinal microbiota or cells. The aim of the present study was to investigate and compare mulberrofuran Y (1), moracin C (2), and mulberrofuran G (3) in an in vitro model of human intestinal bacterial fermentation and in an epithelial model using the Caco-2 cell line. The analysis of compounds by LC-MS-Q-TOF showed sufficient stability in the fermentation model, with no bacterial metabolites detected. However, great differences in the quantity of permeation were observed in the permeability assay. Moreover, mulberrofuran Y (1) and moracin C (2) were observed to be transformed into polar metabolites by conjugation. Among the test compounds, mulberrofuran Y (1) was mostly stable and accumulated in endothelial cells (85.3%) compared with mulberrofuran G (3) and moracin C (2) (14% and 8.2%, respectively). Thus, only a small amount of mulberrofuran Y (1) was conjugated. Moracin C (2) and mulberrofuran G (3) were metabolized almost completely, with only traces of the unchanged molecule being found on the apical and cellular sides of the system. Only conjugates of mulberrofuran Y (1) and moracin C (2) were able to reach the basolateral side. Our results provide the basic description of bioavailability of these three compounds, which is a necessary characteristic for final evaluation of bio-efficacy. MDPI 2021-11-10 /pmc/articles/PMC8625357/ /pubmed/34829035 http://dx.doi.org/10.3390/foods10112754 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vesely, Ondrej
Marsik, Petr
Jarosova, Veronika
Doskocil, Ivo
Smejkal, Karel
Kloucek, Pavel
Havlik, Jaroslav
Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_full Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_fullStr Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_full_unstemmed Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_short Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_sort metabolism of selected 2-arylbenzofurans in a colon in vitro model system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625357/
https://www.ncbi.nlm.nih.gov/pubmed/34829035
http://dx.doi.org/10.3390/foods10112754
work_keys_str_mv AT veselyondrej metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT marsikpetr metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT jarosovaveronika metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT doskocilivo metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT smejkalkarel metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT kloucekpavel metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT havlikjaroslav metabolismofselected2arylbenzofuransinacoloninvitromodelsystem